C/EBPα induces PU.1 and interacts with AP-1 and NF-κB to regulate myeloid development

Blood Cells, Molecules, and Diseases

Volumn 39, Issue 3, 2007, Pages 340-343

  Friedman, Alan D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

c Jun; C EBP ; Myeloid; NF B; PU.1

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HETERODIMER; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUCINE ZIPPER PROTEIN; PROTEIN; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR PU 1; CCAAT ENHANCER BINDING PROTEIN ALPHA; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; COLONY FORMING UNIT GM; COLONY FORMING UNIT M; ENZYME INHIBITION; GENE ACTIVATION; GENE CONTROL; GENETIC TRANSCRIPTION; GRANULOCYTE; INFLAMMATION; MONOCYTE; MYELOID PROGENITOR CELL; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; ANIMAL; HUMAN; METABOLISM; REVIEW;

MUS;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; HUMANS; INFLAMMATION; MYELOID CELLS; MYELOPOIESIS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1;

EID: 34848873739     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.06.010     Document Type: Article

References (45)

1. Friedman A.D. Transcriptional regulation of granulocyte and monocyte development. Oncogene 21 (2002) 3377-3390
2. A.D. Friedman, Transcriptional control of granulocyte and monocyte development, Oncogene (in press).
3. Zhang D.E., Zhang P., Wang N.D., et al. Absence of G-CSF signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 569-574
4. Zhang P., Iwasaki-Arai J., Iwasaki H., et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα. Immunity 21 (2004) 853-863
5. Heath V., Suh H.C., Holman M., et al. C/EBPα deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood 104 (2004) 1639-1647
6. Wang Q., and Friedman A.D. C/EBPs are required for granulopoiesis independent of their induction of the granulocyte-colony stimulating factor receptor. Blood 99 (2002) 2776-2785
7. Iwama A., Osawa M., Hirasawa R., et al. Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell differentiation. J. Exp. Med. 195 (2002) 547-558
8. Scott E.W., Simon M.C., Anastasi J., and Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265 (1994) 1573-1577
9. McKercher S.R., Torbett B.E., Anderson K.L., et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15 (1996) 5647-5658
10. Iwasaki H., Somoza C., Shigematsu H., et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106 (2005) 1590-1600
11. Dahl R., Walsh J.C., Lancki D., et al. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPα ratio and granulocyte colony-stimulating factor. Nat. Immunol. 4 (2003) 1029-1036
12. Laslo P., Spooner C.J., Warmflash A., et al. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 126 (2006) 755-766
13. Rosenbauer F., Wagner K., Kutok J.L., et al. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 36 (2004) 624-630
14. Dakic A., Metcalf D., Di Rago L., et al. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J. Exp. Med. 201 (2005) 1487-1502
15. Wang X., Scott E., Sawyers C.L., and Friedman A.D. C/EBPα by-passes G-CSF signals to rapidly induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32Dcl3 myeloblasts. Blood 94 (1999) 560-571
16. Kummalue T., and Friedman A.D. Cross-talk between regulators of myeloid development: C/EBPα binds and activates the promoter of the PU.1 gene. J. Leukoc. Biol. 72 (2003) 464-470
17. Yeamans C., Wang D., Paz-Priel I., et al. C/EBPα binds and activates the distal PU.1 enhancer. Blood 108 (2006) 347a
18. Umek R.H., Friedman A.D., and McKnight S.L. CCAAT/enhancer binding protein: a component of a differentiation switch. Science 25 (1991) 288-292
19. Porse B.T., Pedersen T.A., Xu X., et al. E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo. Cell 107 (2001) 247-258
20. Wang Q., Cleaves R., Kummalue T., et al. Cell cycle inhibition mediated by the outer surface of the C/EBPα basic region is required but not sufficient for granulopoiesis. Oncogene 22 (2003) 2548-2557
21. Johnson P.F. Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J. Cell Sci. 118 (2005) 2545-2555
22. Wang D., D'Costa J., Civin C.I., and Friedman A.D. C/EBPα directs monocytic commitment of primary myeloid progenitors. Blood 108 (2006) 1223-1229
23. Heavey B., Charalambous C., Cobaleda C., and Busslinger M. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPα and GATA factors. EMBO J. 22 (2003) 3887-3897
24. Xie H., and Graf T. Stepwise reprogramming of B cells into macrophages. Cell 117 (2004) 663-676
25. Laiosa C.V., Stadtfeld M., Xie H., et al. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBPα and PU.1 transcription factors. Immunity 25 (2006) 731-744
26. Fukuchi Y., Shibata F., Ito M., et al. Comprehensive analysis of myeloid lineage conversion using mice expressing an inducible form of C/EBPα. EMBO J. 25 (2006) 3398-3410
27. Lord K.A., Abdollahi A., Hoffman-Liebermann B., and Liebermann D.A. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol. Cell. Biol. 13 (1993) 841-851
28. Szabo E., Preis L.H., and Birrer M.J. Constitutive c-Jun expression induces partial macrophage differentiation in U-937 cells. Cell Growth Differ. 5 (1993) 439-446
29. Li J., King I., and Sartorelli A.C. Differentiation of WEHI-3B D+ myelomonocytic leukemia cells induced by ectopic expression of the protooncogene c-Jun. Cell Growth Differ. 5 (1994) 743-751
30. Kataoka K., Noda M., and Nishizawa M. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol. Cell. Biol. 14 (1994) 700-712
31. Sieweke M.H., Tekotte H., Frampton J., and Graf T. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 85 (1996) 49-60
32. Hegde S.P., Zhao J., Ashmun R.A., and Shapiro L.H. c-Maf induces monocytic differentiation and apoptosis in bipotent myeloid progenitors. Blood 94 (1999) 1578-1589
33. Kelly L.M., Englmeier U., Lafon I., et al. MafB is an inducer of monocytic differentiation. EMBO J. 19 (2000) 1987-1997
34. Rangatia J., Vangala R.K., Treiber N., et al. Downregulation of c-Jun expression by transcription factor C/EBPα is critical for granulocytic lineage commitment. Mol. Cell. Biol. 22 (2002) 8681-8694
35. Cai D.H., Wang D., Keefer J.R., et al. Heterodimers formed via leucine zipper interaction between C/EBPα and c-Jun or c-Fos induce monocytic lineage commitment. Blood 108 (2006) 345a
36. Dunn S.M., Coles L.S., Lang R.K., et al. Requirement for nuclear factor NF-κB p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood 83 (1994) 2469-2479
37. Kunsch C., Lang R.K., and Rosen M.F. Shannon C.A. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J. Immunol. 153 (1994) 153-164
38. Xia C., Cheshire J.K., Patel H., and Woo P. Cross-talk between transcription factors NF-κB and C/EBP in the transcriptional regulation of genes. Int. J. Biochem. Cell Biol. 29 (1997) 1525-1539
39. Maehara K., Hasegawa T., Xiao H., et al. Cooperative interaction of NF-κB and C/EBP binding sites is necessary for manganese superoxide dismutase gene transcription mediated by lipopolysaccharide and interferon γ. FEBS Lett. 449 (1999) 115-119
40. Papin S., Cazeneuve C., Duquesnoy P., et al. The tumor necrosis factor α-dependent activation of the human Mediterranean fever (MEFV) promoter is mediated by a synergistic interaction between C/EBPα and NF-κB p65. J. Biol. Chem. 278 (2003) 48839-48847
41. Matsusaka T., Fujikawa K., Nishio Y., et al. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10193-10197
42. Stein B., Cogswell P.C., and Baldwin Jr. A.S. Functional and physical association between NF-κB and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13 (1993) 3964-3974
43. Paz-Priel I., Cai D.H., Wang D., et al. C/EBPα and C/EBPα myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with NF-κB p50. Mol. Cancer Res. 3 (2005) 585-596
44. Sha W.C., Liou H.C., Tuomanen E.I., and Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80 (1995) 321-330
45. Pearn L., Fisher J., Burnett A.K., and Darley R.L. The role of PKC and PDK1 in monocyte lineage specification by Ras. Blood 109 (2007) 4461-4469